Visit COVID-19 resources

[Skip to Content]

Covid-19

Multi-professional team-working – the experience and lessons from COVID-19

A new report published today reviews the role of multi-professional teams during the pandemic and considers how the members of different occupational groups came together to deliver care differently. Multi-professional team-working – the experience and lessons from COVID-19 published by the Academy of Medical Royal Colleges (AOMRC) focuses on lessons learned about the enablers for

RCOphth responds to select committees and MPs report on Coronavirus: Lessons learned to date 

A joint parliamentary select committee report published yesterday has assessed some of the key decisions the UK has taken during the pandemic and lessons that needed to be learnt. While acknowledging there were some areas where the UK performed well, such as vaccine development and rollout, the report overall is very critical of the UK

Temporary curriculum derogations due to COVID19

Many trainees have lost training time because of redeployments outside of Ophthalmology throughout the pandemic. Even when present in speciality training, opportunities have been reduced due to the limitations imposed by the need for social distancing, reduced outpatient clinic numbers and limited operating theatre lists. The GMC have agreed changes to curriculum requirements at ARCP

Redeployment considerations during the latest pandemic surge

COVID-19 has led to a national lockdown in the New Year with increased infection rates putting immense pressure on frontline services which has meant the redeployment of ophthalmic staff, including ophthalmologists in training is already taking place. The Royal College of Ophthalmologists recognises that this is a necessary step to support the overall critical response

COVID-19 Vaccine Programme

Information regarding the vaccinations programme, including FAQs and latest advice. MHRA guidance for health professionals on Pfizer BioNTech COVID-19 vaccine MHRA information for UK recipients on Pfizer BioNTech COVID-19 vaccine Conditions of MHRA authorisation Government “Green Book” provisional guidance  GMC Guidance :  Q and As on vaccines and guidance on COVID ethical issues Supporting Vulnerable